Authors: Van Beneden, C Balter, S

Citation: C. Van Beneden et S. Balter, An update on the new pneumococcal conjugate vaccine - Response, PEDIAT ANN, 30(9), 2001, pp. 515-516

Authors: Balter, S Van Beneden, C

Citation: S. Balter et C. Van Beneden, An update on the new pneumococcal conjugate vaccine, PEDIAT ANN, 30(6), 2001, pp. 350

Authors: Santosham, M Van Beneden, C Block, S Pelton, SI Black, S",Cogen,"Austrian, R

Citation: M. Santosham et al., Epidemiology of pneumococcal disease, AM J M CARE, 5(17), 1999, pp. S991-S999

Authors: Pelton, SI Santosham, M Van Beneden, C Black, S

Citation: Si. Pelton et al., Prevention of pneumococcal disease in high-risk pediatric groups, AM J M CARE, 5(17), 1999, pp. S1004-S1009

Authors: Black, S Van Beneden, C Pelton, SI Austrian, R Santosham, O Block, S Lieu, T",Cogen

Citation: S. Black et al., The clinical impact of pneumococcal conjugate vaccines, AM J M CARE, 5(17), 1999, pp. S1010-S1017

Authors: Lieu, T Black, S",Cogen,"Block, S",Ray,"Thompson, D Santosham, M Austrian, R Van Beneden, C Pelton, SI

Citation: T. Lieu et al., Economic impact of a pneumococcal conjugate vaccine in managed care, AM J M CARE, 5(17), 1999, pp. S1018-S1023